Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
8
×
drugs
8
×
life sciences
national blog main
raleigh-durham blog main
8
×
raleigh-durham top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
texas blog main
fda
cancer
investing
abbvie
astrazeneca
celgene
eli lilly
merck
pfizer
startups
teva pharmaceutical
What
bio
drug
fda
roundup
annual
companies
conference
drugs
known
latest
led
life
make
medical
new
science
week
adapt
ahead
alzheimer’s
american
approval
approved
arguments
asco
ash
assessed
attention
big
biotech
biotechs
blood
borne
branded
cancers
cash
cells
cellular
changes
choices
Language
unset
Current search:
drugs
×
biotech
×
" raleigh-durham blog main "
×
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
4 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Hatteras Launches New Fund With $94M for Life Science Investments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way